SF2-20974-89522
1 vaccination
1 coded response
7 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 068 / CT
- Registered
- 2023-01-16
- Relationship
- Child or adolescent in my care
- Guardian
- 93F-31717-26088
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2023-01-11
Dose 1 — Pfizer-BioNTech
-
2023-01-16
Registered in v-safe
-
2023-01-16
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Injection site bruising — Feeling: Good · Site: Pain, Redness · Fatigue or tirednessMedDRA releases: 2024-11
- 2023-01-17
- 2023-01-20
- 2023-01-25
- 2023-02-01
- 2023-02-24
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2023-01-11 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release